Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07095842
PHASE2/PHASE3

Prehospital Early Administration of Ketamine for Status Epilepticus in Epileptic Kids (PEAK-SEEK)

Sponsor: Sohag University

View on ClinicalTrials.gov

Summary

The goal of this pragmatic, decentralized, pre-consented, event-driven, randomized controlled trial is to investigate the efficacy of add-on ketamine to second-dose midazolam for prehospital treatment of epileptic children with convulsive status epilepticus.

Official title: Efficacy of Add-on Ketamine With Second-dose Midazolam for Prehospital Treatment of Epileptic Children With Status Epilepticus

Key Details

Gender

All

Age Range

2 Years - 16 Years

Study Type

INTERVENTIONAL

Enrollment

668

Start Date

2025-08-03

Completion Date

2026-08-01

Last Updated

2025-08-05

Healthy Volunteers

No

Interventions

DRUG

Ketamine

Intramuscular ketamine 2 mg/kg (max 90 mg)

DRUG

Midazolam

Intramuscular midazolam 0.2 mg/kg (max 10 mg)

Locations (1)

Department of Pediatrics at Sohag University Hospital

Sohag, Egypt